Pharma Journalist -

Aldevron, a leading research to GMP biomanufacturer of plasmid DNA, mRNA, and proteins, and Ginkgo Bioworks, Inc. ("Ginkgo") announced a manufacturing breakthrough driven by their…
Read More...

Seagen Inc. and RemeGen Co., Ltd. announced that the two companies have entered into an exclusive worldwide licensing agreement to develop and commercialize disitamab vedotin, a novel…
Read More...

To address the ongoing demand for COVID-19 testing and to catalyze safe return of the workforce, Dalrada Corporation is excited to announce that its subsidiary, Dalrada Health, entered…
Read More...

INOVIO a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,…
Read More...

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the European Union (EU) for the treatment of chronic kidney disease (CKD)…
Read More...

Fulgent Genetics, Inc. a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced that…
Read More...

Epizyme, Inc. a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, and HUTCHMED (China) Limited (“HUTCHMED”), announce a…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset Pompe disease, a…
Read More...

Kite, a Gilead Company and Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer…
Read More...

SMi Group reports: Ten key reasons to join SMi’s Next Generation Pharmaceutical Cleanroom conference, convening on 6th and 7th October 2021. The 2nd Annual Next Generation…
Read More...